Эрик Тополь - Будущее медицины: Ваше здоровье в ваших руках

Тут можно читать онлайн Эрик Тополь - Будущее медицины: Ваше здоровье в ваших руках - бесплатно ознакомительный отрывок. Жанр: foreign_edu, издательство Альпина нон-фикшн, год 2016. Здесь Вы можете читать ознакомительный отрывок из книги онлайн без регистрации и SMS на сайте лучшей интернет библиотеки ЛибКинг или прочесть краткое содержание (суть), предисловие и аннотацию. Так же сможете купить и скачать торрент в электронном формате fb2, найти и слушать аудиокнигу на русском языке или узнать сколько частей в серии и всего страниц в публикации. Читателям доступно смотреть обложку, картинки, описание и отзывы (комментарии) о произведении.

Читать книгу

Название:

Будущее медицины: Ваше здоровье в ваших руках
Автор:

Эрик Тополь
Жанр:

foreign_edu
Издательство:

Альпина нон-фикшн
Год:

2016
Город:

Москва
ISBN:

978-5-9614-4338-7
Рейтинг:

5/5. Голосов: 11
Избранное:

Добавить в избранное
Отзывы:

Читать комментарии
Ваша оценка:
100

1

2

3

4

5

Эрик Тополь - Будущее медицины: Ваше здоровье в ваших руках краткое содержание

Будущее медицины: Ваше здоровье в ваших руках - описание и краткое содержание, автор Эрик Тополь, читайте бесплатно онлайн на сайте электронной библиотеки LibKing.Ru

Мир медицины проходит в наши дни революционную трансформацию. Цифровой мониторинг информационных потоков, повсеместное распространение компьютеров, новейшие молекулярные и генетические разработки, направленные на предотвращение болезней, всевозможные медицинские датчики, исследования и анализы, а главное – доступ к данным о собственном здоровье – в корне меняют систему здравоохранения.
Известный врач, ученый, первопроходец передовых технологий в медицине Эрик Тополь считает, что традиционная субординация в отношениях врача и пациента уходит в прошлое, человек сам становится хозяином своего здоровья, и неизбежная демократизация медицины обещает нам ее эффективность и доступность.

Будущее медицины: Ваше здоровье в ваших руках - читать онлайн бесплатно ознакомительный отрывок

Будущее медицины: Ваше здоровье в ваших руках - читать книгу онлайн бесплатно (ознакомительный отрывок), автор Эрик Тополь

Тёмная тема

Шрифт:

↓

↑

Сбросить

Интервал:

↓

↑

Закладка:

Сделать

43. L. Jamal, "What Do We Gain or Lose by Regulating 23andMe?" Berman Institute of Bioethics Bulletin , November 27, 2013, http://bioethicsbulletin.org/archive/what-do-we-gain-or-lose-by-regulating-23andme/print/.

44. T. Hay, "23andMe Flap With FDA Just a Bump in the Road, One Genetics-Testing Investor Says," Wall Street Journal , December 16, 2013, http://blogs.wsj.com/venturecapital/2013/12/16/23andme-flap-with-fda-just-a-bump-in-the-road-one-genetics-testing-investor-says/tab/print/.

45. H. Greely, "The FDA Drops an Anvil on 23andMe – Now What?" Law and Biosciences Blog, November 25, 2013, https://blogs.law.stanford.edu/lawandbiosciences/2013/11/25/the-fda-drops-an-anvil-on-23andme-now-what/.

46. M. F. Murray, "Why We Should Care About What We Get for 'Only $99' From a Personal Genomic Service," Annals of Internal Medicine 160, no. 7 (2014): 507–508.

47. G. Neff, "In the Battle Over Personal Health Data, 23andMe and the FDA Are Both Wrong," Slate, December 13, 2013, http://www.slate.com/blogs/future_tense/2013/ 12/13/_23andme_vs_the_fda_both_are_wrong.html.

48. R. Bailey, "Let My Genes Go! And Leave 23andMe Alone," Reason.com, November 29, 2013, http://reason.com/archives/2013/11/29/why-the-fda-should-leave-23andme-alone/print.

49. S. Usdin, "The Sky Isn't Falling," BioCentury, June 17, 2013, http://www.biocentury.com/biotech-pharma-news/politics/2013-06-17/scotus-myriad-protects-biotech-patenting-but-leaves-important-gray-areas-a13.

50. E. Vayena, "Direct-to-Consumer Genomics on the Scales of Autonomy," Journal of Medical Ethics, May 5, 2014, http://jme.bmj.com/content/early/2014/05/05/medethics-2014-102026.full.

51. J. K. Wagner, "The Sky Is Falling for Personal Genomics! Oh, Nevermind. It's Just a Cease & Desist Letter from the FDA to 23andMe," Genomics Law Report, December 3, 2013, http://www.genomicslawreport.com/index.php/2013/12/03/the-sky-is-falling-for-personal-genomics-oh-nevermind-its-just-a-cease-desist-letter-from-the-fda-to-23andme/.

52. "Doing the Genomic Revolution Right," Huffngton Post , December 20, 2013, http://www.huffingtonpost.com/tricia-page/doing-the-genomic-revolution-right_b_4480887.html?view=print&comm_ref=false.

53. A. J. Burke, "23andMe's FDA Battle Provokes Furious Debate," Techonomy, December 2, 2013, http://techonomy.com/2013/12/just-tip-iceberg-23andme-medicine/.

54. "Multiple Testing an Issue for 23andMe," Bits of DNA, November 30, 2013, http://liorpachter.wordpress.com/2013/11/30/23andme-genotypes-are-all-wrong/.

55. "23andMe: State of Debate," Bio-IT World, November 27, 2013, http://www.bio-itworld.com/2013/11/27/23andme-state-of-debate.html.

56. M. Hiltzik, "23andMe's Genetic Tests Are More Misleading Than Helpful," Los Angeles Times, December 15, 2013, http://www.latimes.com/business/la-fi-hiltzik-20131215,0,1359952.column.

57. K. Hill, "The FDA Just Ruined Your Plans to Buy 23andMe's DNA Test as a Christmas Present," Forbes, November 25, 2013, http://www.forbes.com/sites/kashmirhill/2013/11/25/fda-23andme/.

58. L. Kish, "The Social Conquest of Medicine: The 23andMe and Conflict," HL7 Standards , January 7, 2014, http://www.hl7standards.com/blog/2014/01/07/23andme/.

59. J. Kiss, "23andMe Admits FDA Order 'Significantly Slowed Up' New Customers," The Guardian , March 9, 2014, http://www.theguardian.com/technology/2014/mar/09/google-23andme-anne-wojcicki-genetics-healthcare-dna/print.

60. A. Krol, "Show, Don't Tell: 23andMe Pursues Health Research in the Shadow of the FDA," Bio-IT World, March 24, 2014, http://www.bio-it world.com/2014/3/24/show-dont-tell-23andme-pursues-health-research-shadow-fda.html.

61. D. Kroll, "Why The FDA Can't Be Flexible With 23andMe," Forbes, November 28, 2013, http://www.forbes.com/sites/davidkroll/2013/11/28/why-the-fda-cant-be-flexible-with-23andme-by-law/.

62. P. Loftus, "23andMe Stops Genetic Test Marketing," Wall Street Journal , December 2, 2013, http://online.wsj.com/news/articles/ SB10001424052702304579404579234503409624522.

63. P. Loftus, "Genetic Test Service 23andMe Ordered to Halt Marketing by FDA," Wall Street Journal , November 25, 2013: http://online.wsj.com/news/articles/ SB10001424052702304281004579219893863966448.

64. P. Loftus and R. Winslow, "23andMe CEO Responds to FDA Warning Letter," Wall Street Journal , November 27, 2013, http://online.wsj.com/news/articles/ SB10001424052702303332904579224093983156448.

65. G. Lyon, "Stopping 23andMe Will Only Delay the Revolution Medicine Needs," The Conversation, November 25, 2013, http://theconversation.com/stopping-23andme-will-only-delay-the-revolution-medicine-needs-20743.

66. V. Hughes, "23 a nd You," Medium , December 4, 2013, https://medium.com/matter/66e87553d22c.

67. "The FDA vs. 23andMe: A Lesson for Health Care Entrepreneurs," Knowledge at Wharton(K@W) , December 18, 2013, http://knowledge.wharton.upenn.edu/article/fda-vs-23andme-lesson-health-care-entrepreneurs/.

68. R. Bailey, "Leave 23andMe Alone," Reason.com, February 25, 2014, http://reason.com/archives/2014/02/25/leave-23andme-alone/print.

69. H. Binswanger, "FDA Says, 'No Gene Test for You: You Can't Handle the Truth,'" Forbes , November 26, 2013, http://www.forbes.com/sites/harrybinswanger/2013/11/26/fda-says-no-gene-test-for-you-you-cant-handle-the-truth/.

70. M. Allison, "Direct-to-Consumer Genomics Reinvents Itself," Nature Biotechnology 30, no. 11 (2012): 1027–1029.

71. G. J. Annas and S. Elias, "23andMe and the FDA," New England Journal of Medicine 370 (2014): 985–988.

72. M. White, "The FDA is Not Anti-Genetics," Pacific Standard , January 17, 2014: http://www.psmag.com/navigation/nature-and-technology/fda-anti-genetics-72987/.

73. C. Wood, "Does the FDA Think You're Stupid?" Casey Research, December 5, 2013, http://www.caseyresearch.com/cdd/does-the-fda-think-youre-stupid.

74. C. Farr, "23andMe Remains Optimistic Despite FDA Issues: 'We Are Not Going Anywhere' (Exclusive)," Venture Beat, December 7, 2013, http://venturebeat.com/2013/12/07/23andme-remains-defiant-despite-fda-issues-we-are-not-going-anywhere-exclusive/2/.

75. L. Downes and P. Nunes, "Regulating 23andMe to Death Won't Stop the New Age of Genetic Testing," Wired, January 1, 2014, http://www.wired.com/opinion/2014/01/the-fda-may-win-the-battle-this-holiday-season-but-23andme-will-win-the-war/.

76. N. S. Downing and J. S. Ross, "Innovation, Risk, and Patient Empowerment The FDA-Mandated Withdrawal of 23andMe's Personal Genome Service," Journal of the American Medical Association 311, no. 8 (2014): 793–794.

77. "Irresistible Force Meets Immoveable Object," Nature Biotechnology 32, no. 1 (2014): 1.

78. D. Dobbs, "The F.D.A. vs. Personal Genetic Testing," New Yorker, November 27, 2013, http://www.newyorker.com/online/blogs/elements/2013/11/the-fda-vs-personal-genetic-testing.html?printable=true&currentPage=all.

79. G. Marchant, "The FDA Could Set Personal Genetics Rights Back Decades," Slate , November 26, 2013, http://www.slate.com/articles/technology/future_tense /2013/11/_23andme_fda_letter_premarket_approval_ requirement_could_kill_at_home_genetic.html.

80. U. Francke et al., "Dealing with the Unexpected: Consumer Responses to Direct-Access BRCA Mutation Testing," PeerJ , February 12, 2013, https://peerj.com/articles/8/.

81. R. Epstein, "The FDA Strikes Again: Its Ban on Home Testing Kits Is, as Usual, Likely to Do More Harm Than Good," Point of Law, November 27, 2013: http://www.pointoflaw.com/archives/2013/11/t.php.

82. A. Wolfe, "Anne Wojcicki's Quest for Better Health Care," Wall Street Journal , June 27, 2014, http://online.wsj.com/articles/anne-wojcickis-quest-for-better-health-care-1403892088.

83. C. Bloss, N. Schork, and E. Topol, "Effect of Direct-to-Consumer Genomewide Profiling to Assess Disease Risk," New England Journal of Medicine 364, no. 6 (2011): 524–534.

84. R. C. Green and N. A. Farahany, "The FDA Is Overcautious on Consumer Genomics," Nature 505 (2014): 2.

85. R. Leuty, "23andMe's Andy Page Gets Disruptive with the Masses," San Francisco Business Times, October 22, 2013, http://www.bizjournals.com/sanfrancisco/blog/biotech/ 2013/10/23andme-andy-page-anne-wojcicki.html?page=all.

86. N. Fliesler, "Direct-to-Consumer Genetic Testing: A Case of Potential Harm," Boston Children's Hospital science and clinical innovation blog , May 5, 2014, http://vectorblog.org/2014/05/direct-to-consumer-genetic-testing-a-case-of-potential-harm/.

87. S. Pasha, "23andMe Revealed a Condition It Took My Doctors Six Years to Diagnose," Quartz , November 28, 2013, http://qz.com/151817/23andme-revealed-a-condition-it-took-my-doctors-six-years-to-diagnose/.

88. "The FDA and Thee," Wall Street Journal, November 25, 2013: http://online.wsj.com/news/articles/SB10001424052702304465604579220003539640102.

89. M. A. Hamburg, "FDA Supports Development of Innovative Genetic Tests," Wall Street Journal , December 3, 2013: http://online.wsj.com/news/articles/ SB10001424052702304011304579222111609444156.

90. F. S. Collins and M. A. Hamburg, "First FDA Authorization for Next-Generation Sequencer," New England Journal of Medicine 369 (2013): 2369–2371.

91. "Regulation of Laboratory Developed Tests (LDTs)," American Society for Clinical Pathology, 2010, http://www.ascp.org/PDF/Advocacy/Regulation-of-laboratory-developed-tests-LDTs.aspx.

92. P. Offt, Do You Believe in Magic? (New York, NY: HarperCollins, 2013).

93. A. O'Connor, "Spike in Harm to Liver Is Tied to Dietary Aids," New York Times, December 22, 2013, http://www.nytimes.com/2013/12/22/us/spike-in-harm-to-liver-is-tied-to-dietary-aids.html.

94. J. Pickrell, "Should the FDA Regulate the Interpretation of Traditional Epidemiology?" Genomes Unzipped, February 12, 2013, http://www.genomesunzipped.org/2013/12/should-the-fda-regulate-the-interpretation-of-traditional-epidemiology.php.

95. D. Dobbs, "Is the National Cancer Institute Telling Me to Remove My Breasts?" Neuron Culture, December 2, 2013, http://daviddobbs.net/smoothpebbles/is-the-national-cancer-institute-telling-me-to-remove-my-breasts/.

96. M. Eisen, "FDA vs. 23andMe: How Do We Want Genetic Testing to Be Regulated?" it is NOT junk, November 26, 2013, http://www.michaeleisen.org/blog/?p=1480.

97. "The FDA and me," Nature 504 (2013): 7–8.

98. C. Seife, "23andMe Is Terrifying, but Not for the Reasons the FDA Thinks," Scientific American , November 27, 2013, http://www.scientificamerican.com/article.cfm?id=23andme-is-terrifying-but-not-for-reasons-fda.

99. A. R. Venkitaraman, "Cancer Suppression by the Chromosome Custodians, BRCA1 and BRCA2," Science 343 (2014): 1470–1475.

100. D. B. Agus, "The Outrageous Cost of a Gene Test," New York Times , May 21, 2013, http://www.nytimes.com/2013/05/21/opinion/the-outrageous-cost-of-a-gene-test.html.

101. Supreme Court of the United States, "Association for Molecular Pathology et al. versus Myriad Genetics, Inc., et al." SCOTUS, 2013, http://www.supremecourt.gov/opinions/12pdf/12-398_1b7d.pdf.

102. M. Specter, "Can We Patent Life?" New Yorker , April 1, 2013, http://www.newyorker.com/online/blogs/elements/2013/04/myriad-genetics-patent-genes.html.

103. E. Marshall, "Supreme Court Rules Out Patents on 'Natural' Genes," Science 340 (2013): 1387–1388.